IHS Chemical Week

EnviroTech :: R&D

Nicholas Piramal to Spin Off R&D Unit

9:00 AM MDT | September 12, 2007 | Deepti Ramesh

Pharmaceutical company Nicholas Piramal India Ltd. (NPIL; Mumbai) says it plans to demerge its R&D unit, creating a separate, independent company focused on developing novel drugs, otherwise known as new chemical entities (NCE). The demerger will be in the form of a spin-off to shareholders. NPIL will have an 18% stake in the new company, and NPIL’s shareholders will hold the rest. A proposal for the demerger has been approved by the NPIL board, and awaits regulatory and other approvals. NPIL will transfer net assets worth about $24 million to the new...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa